Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Por um escritor misterioso
Descrição
Jumbo phage PCH45 evades type I, but not type III, CRISPR–Cas
A jumbo phage that forms a nucleus-like structure evades CRISPR–Cas DNA targeting but is vulnerable to type III RNA-based immunity
Viral speciation through subcellular genetic isolation and virogenesis incompatibility
Identification of the bacteriophage nucleus protein interaction network
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
The jumbo phage is resistant to type I CRISPR-Cas immunity a. tblastx
Intracellular Organization by Jumbo Bacteriophages
The Rcs stress response inversely controls surface and CRISPR–Cas adaptive immunity to discriminate plasmids and phages
IJMS, Free Full-Text
A cytoskeletal vortex drives phage nucleus rotation during jumbo phage replication in E. coli - ScienceDirect
Type III CRISPR-Cas Immunity: Major Differences Brushed Aside: Trends in Microbiology
Type III CRISPR-Cas provides resistance against nucleus-forming jumbo phages via abortive infection - ScienceDirect
de
por adulto (o preço varia de acordo com o tamanho do grupo)
